Upgrade to SI Premium - Free Trial

Rothschild Redburn Upgrades CME Group (CME) to Buy

June 11, 2026 4:21 AM
Rothschild Redburn analyst Simon Clinch upgraded CME Group (NASDAQ: CME) from Neutral to Buy with a price target of $323.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Upgrades